Home > Healthcare > Biotechnology > Biotechnology R&D > Protein Labeling Market

Protein Labeling Market Analysis

  • Report ID: GMI6494
  • Published Date: Aug 2023
  • Report Format: PDF

Protein Labeling Market Analysis

By product type, the protein labeling market is classified into kits & reagents and services. The kits & reagents accounted for 69.3% of the business share in 2022 and is projected to witness robust growth over the analysis timeframe. Protein labeling kits and reagents offer a streamlined solution for researchers, providing ready-to-use tools to attach markers to proteins. This efficiency saves time, ensures accuracy, and reduces potential errors, benefiting both laboratories and those new to protein labeling. Also, with optimized protocols and simplified workflows, these kits enhance reproducibility and lower the risk of experimental variations. Thus, by labeling processes, protein labeling kits and reagents enable researchers to focus on data analysis and scientific insights, thereby contributing to advancements in research, diagnostics, and therapeutic development.
 

Protein Labeling Market Revenue Share, By Labeling Method, (2022)

Based on labeling method, the protein labeling market is segmented into in-vitro and in-vivo. The in-vitro labeling method segment is expected to register USD 4.4 billion by 2032. In-vitro protein labeling approach involves labeling proteins outside of living organisms, enabling precise control over conditions and reactions. Also, in-vitro labeling ensures consistent and reproducible results, reducing experimental variability. It allows for customization by selecting specific labeling tags and reagents according to research needs. Moreover, this method minimizes potential interference with cellular processes, maintaining protein functionality and enhances research efficiency, thereby accelerating the segment expansion.
 

By application, the protein labeling market is segmented into cell-based assays, fluorescence microscopy, immunological techniques, mass spectrometry and protein microarray. The immunological techniques segment accounted for significant market revenue in 2022 and is expected to grow at 9.6% during the forecast period. Protein labeling through immunological approach involves attaching labels to proteins using antibodies, enabling highly specific and targeted labeling. Also, it enables in detecting and quantifying proteins in complex biological samples, enhancing disease diagnostics and biomarker discovery. Furthermore, it offers precision and allows researchers to study protein expression, interactions, and localization with exceptional accuracy.
 

The end-user in protein labeling market is categorized into hospitals and clinics, diagnostic laboratories, pharmaceutical and biotechnology companies and other end-users. The pharmaceutical and biotechnology ccompanies segment accounted for USD 992.8 million market revenue in 2022 and is estimated to grow at significant pace during the forecast period. Increasing segmental growth is owing to precise analysis of interactions, functions, and mechanisms of action offered by protein labeling enables pharmaceutical and biotechnology companies to accelerate their R&D process.
 

Growing focus on targeted therapies and precision medicine is significantly propelling the adoption of protein labeling the pharmaceutical and biotechnology companies. Thus, by leveraging protein labeling capabilities, companies can streamline R&D efforts, improve decision-making, and ultimately accelerate the commercialization of innovative therapies into market, thereby driving the segmental growth.
 

U.S. Protein Labeling Market Size, 2020 – 2032 (USD Million)

North America protein labeling market accounted for 42.8% business share in 2022 and is anticipated to grow at considerable growth rate during the forecast timeframe. Increasing R&D investments for drug discovery, personalized medicine, and disease diagnostics in the region is expected to significantly proliferate the market growth. Also, presence of key market players especially in U.S. contributes to the growth of market. Further, growing demand for effective disease diagnosis & treatment, favorable government regulations and developed R&D infrastructure further support the expansion of protein labeling, thereby contributing to the market progress in the North America region.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Protein labeling industry was worth USD 2.2 billion in 2022 and is estimated to expand at 10.6% CAGR from 2023-2032 driven by the increasing advancements in molecular biology along with rising biopharmaceutical research, drug development, and diagnostics.

The kits & reagents segment accounted for 69.3% of the market share in 2022 and is projected to expand substantially through 2032 owing to their rising need for streamlined solution for researchers.

North America held 42.8% share of the protein labeling market in 2022 and is anticipated to grow at considerable CAGR through 2032 driven by the increasing R&D investments for drug discovery, personalized medicine, and disease diagnostics in the region.

Some of the top firms operating in the market are Thermo Fisher Scientific Inc., Merck & Co., Inc, F. Hoffmann-La Roche, Promega Corporation, Bio-Rad Laboratories among others.

Protein Labeling Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 369
  • Countries covered: 19
  • Pages: 220
 Download Free Sample